Novel peptides and uses thereof for treating cancer
AssigneeSymthera Canada Ltd.
InventorChai EZERZER
Life of this patent
Estimating the term…
Abstract
Presented herein are cancer peptide agents and uses thereof for treating cancer and/or inhibiting metastasis. Also presented herein are methods of treating cancer, or inhibiting metastasis of cancer in a subject, comprising administering a therapeutically effective amount of a composition comprising one or more cancer peptide agents to the subject. Also presented herein is a method of treating a cancer in a subject, or inhibiting metastasis of a cancer in a subject that comprises administering a therapeutically effective amount of a composition comprising one or more cancer peptide agents, and administering a chemotherapy or chemotherapeutic agent.
Claims23
A method of treating cancer in a subject in need thereof comprising administering a therapeutically effective amount of a composition comprising one or more cancer peptide agents and a preservative to the subject, wherein the one or more cancer peptide agents consists of an amino acid sequence selected from the amino acid sequence of DVWSXGXXXY (SEQ ID NO:1), DXWSXGCXXY (SEQ ID NO:2), DXWSXGXXLY (SEQ ID NO:3) and KSDXWSLGCXLY (SEQ ID N0:4), wherein X is one or more amino acids and the one or more cancer peptide agents has a length of 15 amino acids or less.
(canceled)
(canceled)
(canceled)
(canceled)
A pharmaceutical composition comprising one or more cancer peptide agents and a preservative, wherein the one or more cancer peptide agents consists of an amino acid sequence selected from the amino acid sequence of DVWSXGXXXY (SEQ ID NO:1), DXWSXGCXXY (SEQ ID NO:2), DXWSXGXXLY (SEQ ID NO:3) and KSDXWSLGCXLY (SEQ ID NO:4), and one or more pharmaceutically acceptable excipients or carriers, wherein X is one or more amino acids and the one or more cancer peptide agents has a length of 15 amino acids or less.
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.